The global market for Onco-hematology Molecular Testing was valued at US$ 639 million in the year 2024 and is projected to reach a revised size of US$ 1440 million by 2031, growing at a CAGR of 12.5% during the forecast period.

Onco-hematology Molecular Testing Market

North American market for Onco-hematology Molecular Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Onco-hematology Molecular Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Onco-hematology Molecular Testing in National Reference Lab / Specialty Lab is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Onco-hematology Molecular Testing include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Cepheid, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Onco-hematology Molecular Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Onco-hematology Molecular Testing.

The Onco-hematology Molecular Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Onco-hematology Molecular Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Onco-hematology Molecular Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Onco-hematology Molecular Testing Market Report

Report Metric	Details
Report Name	Onco-hematology Molecular Testing Market
Accounted market size in year	US$ 639 million
Forecasted market size in 2031	US$ 1440 million
CAGR	12.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	qPCR dPCR Next-Generation Sequencing Others
Segment by Application	National Reference Lab / Specialty Lab University Hospital Community Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Cepheid
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Onco-hematology Molecular Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Onco-hematology Molecular Testing Market growing?

Ans: The Onco-hematology Molecular Testing Market witnessing a CAGR of 12.5% during the forecast period 2025-2031.

What is the Onco-hematology Molecular Testing Market size in 2031?

Ans: The Onco-hematology Molecular Testing Market size in 2031 will be US$ 1440 million.

Who are the main players in the Onco-hematology Molecular Testing Market report?

Ans: The main players in the Onco-hematology Molecular Testing Market are Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Cepheid

What are the Application segmentation covered in the Onco-hematology Molecular Testing Market report?

Ans: The Applications covered in the Onco-hematology Molecular Testing Market report are National Reference Lab / Specialty Lab, University Hospital, Community Hospital

What are the Type segmentation covered in the Onco-hematology Molecular Testing Market report?

Ans: The Types covered in the Onco-hematology Molecular Testing Market report are qPCR, dPCR, Next-Generation Sequencing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Onco-hematology Molecular Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 qPCR

1.2.3 dPCR

1.2.4 Next-Generation Sequencing

1.2.5 Others

1.3 Market by Application

1.3.1 Global Onco-hematology Molecular Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 National Reference Lab / Specialty Lab

1.3.3 University Hospital

1.3.4 Community Hospital

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Onco-hematology Molecular Testing Market Perspective (2020-2031)

2.2 Global Onco-hematology Molecular Testing Growth Trends by Region

2.2.1 Global Onco-hematology Molecular Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Onco-hematology Molecular Testing Historic Market Size by Region (2020-2025)

2.2.3 Onco-hematology Molecular Testing Forecasted Market Size by Region (2026-2031)

2.3 Onco-hematology Molecular Testing Market Dynamics

2.3.1 Onco-hematology Molecular Testing Industry Trends

2.3.2 Onco-hematology Molecular Testing Market Drivers

2.3.3 Onco-hematology Molecular Testing Market Challenges

2.3.4 Onco-hematology Molecular Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Onco-hematology Molecular Testing Players by Revenue

3.1.1 Global Top Onco-hematology Molecular Testing Players by Revenue (2020-2025)

3.1.2 Global Onco-hematology Molecular Testing Revenue Market Share by Players (2020-2025)

3.2 Global Onco-hematology Molecular Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Onco-hematology Molecular Testing Revenue

3.4 Global Onco-hematology Molecular Testing Market Concentration Ratio

3.4.1 Global Onco-hematology Molecular Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Onco-hematology Molecular Testing Revenue in 2024

3.5 Global Key Players of Onco-hematology Molecular Testing Head office and Area Served

3.6 Global Key Players of Onco-hematology Molecular Testing, Product and Application

3.7 Global Key Players of Onco-hematology Molecular Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Onco-hematology Molecular Testing Breakdown Data by Type

4.1 Global Onco-hematology Molecular Testing Historic Market Size by Type (2020-2025)

4.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Type (2026-2031)

5 Onco-hematology Molecular Testing Breakdown Data by Application

5.1 Global Onco-hematology Molecular Testing Historic Market Size by Application (2020-2025)

5.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Onco-hematology Molecular Testing Market Size (2020-2031)

6.2 North America Onco-hematology Molecular Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Onco-hematology Molecular Testing Market Size by Country (2020-2025)

6.4 North America Onco-hematology Molecular Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Onco-hematology Molecular Testing Market Size (2020-2031)

7.2 Europe Onco-hematology Molecular Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Onco-hematology Molecular Testing Market Size by Country (2020-2025)

7.4 Europe Onco-hematology Molecular Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Onco-hematology Molecular Testing Market Size (2020-2031)

8.2 Asia-Pacific Onco-hematology Molecular Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Onco-hematology Molecular Testing Market Size (2020-2031)

9.2 Latin America Onco-hematology Molecular Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Onco-hematology Molecular Testing Market Size by Country (2020-2025)

9.4 Latin America Onco-hematology Molecular Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Onco-hematology Molecular Testing Market Size (2020-2031)

10.2 Middle East & Africa Onco-hematology Molecular Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Asusragen, Inc.

11.1.1 Asusragen, Inc. Company Details

11.1.2 Asusragen, Inc. Business Overview

11.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Introduction

11.1.4 Asusragen, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.1.5 Asusragen, Inc. Recent Development

11.2 Bio-Rad Laboratories,Inc.

11.2.1 Bio-Rad Laboratories,Inc. Company Details

11.2.2 Bio-Rad Laboratories,Inc. Business Overview

11.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Introduction

11.2.4 Bio-Rad Laboratories,Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.2.5 Bio-Rad Laboratories,Inc. Recent Development

11.3 ICON Plc

11.3.1 ICON Plc Company Details

11.3.2 ICON Plc Business Overview

11.3.3 ICON Plc Onco-hematology Molecular Testing Introduction

11.3.4 ICON Plc Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.3.5 ICON Plc Recent Development

11.4 Integrated DNA Technologies, Inc.

11.4.1 Integrated DNA Technologies, Inc. Company Details

11.4.2 Integrated DNA Technologies, Inc. Business Overview

11.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Introduction

11.4.4 Integrated DNA Technologies, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.4.5 Integrated DNA Technologies, Inc. Recent Development

11.5 Illumina, Inc.

11.5.1 Illumina, Inc. Company Details

11.5.2 Illumina, Inc. Business Overview

11.5.3 Illumina, Inc. Onco-hematology Molecular Testing Introduction

11.5.4 Illumina, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.5.5 Illumina, Inc. Recent Development

11.6 Invivoscribe, Inc.

11.6.1 Invivoscribe, Inc. Company Details

11.6.2 Invivoscribe, Inc. Business Overview

11.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Introduction

11.6.4 Invivoscribe, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.6.5 Invivoscribe, Inc. Recent Development

11.7 QIAGEN N.V.

11.7.1 QIAGEN N.V. Company Details

11.7.2 QIAGEN N.V. Business Overview

11.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Introduction

11.7.4 QIAGEN N.V. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.7.5 QIAGEN N.V. Recent Development

11.8 Thermo Fisher Scientific, Inc.

11.8.1 Thermo Fisher Scientific, Inc. Company Details

11.8.2 Thermo Fisher Scientific, Inc. Business Overview

11.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Introduction

11.8.4 Thermo Fisher Scientific, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.8.5 Thermo Fisher Scientific, Inc. Recent Development

11.9 Cepheid

11.9.1 Cepheid Company Details

11.9.2 Cepheid Business Overview

11.9.3 Cepheid Onco-hematology Molecular Testing Introduction

11.9.4 Cepheid Revenue in Onco-hematology Molecular Testing Business (2020-2025)

11.9.5 Cepheid Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bio-Rad Laboratories Inc

List of Tables

Table 1. Global Onco-hematology Molecular Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of qPCR

Table 3. Key Players of dPCR

Table 4. Key Players of Next-Generation Sequencing

Table 5. Key Players of Others

Table 6. Global Onco-hematology Molecular Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Onco-hematology Molecular Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Onco-hematology Molecular Testing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Onco-hematology Molecular Testing Market Share by Region (2020-2025)

Table 10. Global Onco-hematology Molecular Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Onco-hematology Molecular Testing Market Share by Region (2026-2031)

Table 12. Onco-hematology Molecular Testing Market Trends

Table 13. Onco-hematology Molecular Testing Market Drivers

Table 14. Onco-hematology Molecular Testing Market Challenges

Table 15. Onco-hematology Molecular Testing Market Restraints

Table 16. Global Onco-hematology Molecular Testing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Onco-hematology Molecular Testing Market Share by Players (2020-2025)

Table 18. Global Top Onco-hematology Molecular Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onco-hematology Molecular Testing as of 2024)

Table 19. Ranking of Global Top Onco-hematology Molecular Testing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Onco-hematology Molecular Testing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Onco-hematology Molecular Testing, Headquarters and Area Served

Table 22. Global Key Players of Onco-hematology Molecular Testing, Product and Application

Table 23. Global Key Players of Onco-hematology Molecular Testing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Onco-hematology Molecular Testing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Onco-hematology Molecular Testing Revenue Market Share by Type (2020-2025)

Table 27. Global Onco-hematology Molecular Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Onco-hematology Molecular Testing Revenue Market Share by Type (2026-2031)

Table 29. Global Onco-hematology Molecular Testing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Onco-hematology Molecular Testing Revenue Market Share by Application (2020-2025)

Table 31. Global Onco-hematology Molecular Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Onco-hematology Molecular Testing Revenue Market Share by Application (2026-2031)

Table 33. North America Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Onco-hematology Molecular Testing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Onco-hematology Molecular Testing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Onco-hematology Molecular Testing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Onco-hematology Molecular Testing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Onco-hematology Molecular Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Onco-hematology Molecular Testing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Onco-hematology Molecular Testing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Onco-hematology Molecular Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Asusragen, Inc. Company Details

Table 49. Asusragen, Inc. Business Overview

Table 50. Asusragen, Inc. Onco-hematology Molecular Testing Product

Table 51. Asusragen, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 52. Asusragen, Inc. Recent Development

Table 53. Bio-Rad Laboratories,Inc. Company Details

Table 54. Bio-Rad Laboratories,Inc. Business Overview

Table 55. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product

Table 56. Bio-Rad Laboratories,Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 57. Bio-Rad Laboratories,Inc. Recent Development

Table 58. ICON Plc Company Details

Table 59. ICON Plc Business Overview

Table 60. ICON Plc Onco-hematology Molecular Testing Product

Table 61. ICON Plc Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 62. ICON Plc Recent Development

Table 63. Integrated DNA Technologies, Inc. Company Details

Table 64. Integrated DNA Technologies, Inc. Business Overview

Table 65. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product

Table 66. Integrated DNA Technologies, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 67. Integrated DNA Technologies, Inc. Recent Development

Table 68. Illumina, Inc. Company Details

Table 69. Illumina, Inc. Business Overview

Table 70. Illumina, Inc. Onco-hematology Molecular Testing Product

Table 71. Illumina, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 72. Illumina, Inc. Recent Development

Table 73. Invivoscribe, Inc. Company Details

Table 74. Invivoscribe, Inc. Business Overview

Table 75. Invivoscribe, Inc. Onco-hematology Molecular Testing Product

Table 76. Invivoscribe, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 77. Invivoscribe, Inc. Recent Development

Table 78. QIAGEN N.V. Company Details

Table 79. QIAGEN N.V. Business Overview

Table 80. QIAGEN N.V. Onco-hematology Molecular Testing Product

Table 81. QIAGEN N.V. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 82. QIAGEN N.V. Recent Development

Table 83. Thermo Fisher Scientific, Inc. Company Details

Table 84. Thermo Fisher Scientific, Inc. Business Overview

Table 85. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product

Table 86. Thermo Fisher Scientific, Inc. Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 87. Thermo Fisher Scientific, Inc. Recent Development

Table 88. Cepheid Company Details

Table 89. Cepheid Business Overview

Table 90. Cepheid Onco-hematology Molecular Testing Product

Table 91. Cepheid Revenue in Onco-hematology Molecular Testing Business (2020-2025) & (US$ Million)

Table 92. Cepheid Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Onco-hematology Molecular Testing Picture

Figure 2. Global Onco-hematology Molecular Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Onco-hematology Molecular Testing Market Share by Type: 2024 VS 2031

Figure 4. qPCR Features

Figure 5. dPCR Features

Figure 6. Next-Generation Sequencing Features

Figure 7. Others Features

Figure 8. Global Onco-hematology Molecular Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Onco-hematology Molecular Testing Market Share by Application: 2024 VS 2031

Figure 10. National Reference Lab / Specialty Lab Case Studies

Figure 11. University Hospital Case Studies

Figure 12. Community Hospital Case Studies

Figure 13. Onco-hematology Molecular Testing Report Years Considered

Figure 14. Global Onco-hematology Molecular Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Onco-hematology Molecular Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Onco-hematology Molecular Testing Market Share by Region: 2024 VS 2031

Figure 17. Global Onco-hematology Molecular Testing Market Share by Players in 2024

Figure 18. Global Top Onco-hematology Molecular Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onco-hematology Molecular Testing as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Onco-hematology Molecular Testing Revenue in 2024

Figure 20. North America Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Onco-hematology Molecular Testing Market Share by Country (2020-2031)

Figure 22. United States Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Onco-hematology Molecular Testing Market Share by Country (2020-2031)

Figure 26. Germany Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Onco-hematology Molecular Testing Market Share by Region (2020-2031)

Figure 34. China Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Onco-hematology Molecular Testing Market Share by Country (2020-2031)

Figure 42. Mexico Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Onco-hematology Molecular Testing Market Share by Country (2020-2031)

Figure 46. Turkey Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Onco-hematology Molecular Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Asusragen, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 50. Bio-Rad Laboratories,Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 51. ICON Plc Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 52. Integrated DNA Technologies, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 53. Illumina, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 54. Invivoscribe, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 55. QIAGEN N.V. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 57. Cepheid Revenue Growth Rate in Onco-hematology Molecular Testing Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions